TSS
HAE icon

Two Sigma Securities’s Haemonetics HAE Stock Holding History

Two Sigma Securities’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-2,996
Closed -$222K – 2851
2022
Q3 		$222K Buy
+2,996
New +$215K 0.01% 1856
2020
Q1 		– Sell
-2,218
Closed -$255K – 1730
2019
Q4 		$255K Buy
+2,218
New +$268K ﹤0.01% 1909

Other funds holding HAE

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Two Sigma Securities's HAE Position: Q4 2022 in Review

Two Sigma Securities sold out of Haemonetics (HAE) in Q4 2022, closing a stake of 2,996 shares — an estimated $222K sold.

Two Sigma Securities first reported a position in HAE in Q4 2019 and held it in 2 quarters. The position peaked at $255K in Q4 2019. 294 funds tracked by Wall St. Rank hold HAE as of Q4 2022.

  • Two Sigma Securities reported no remaining Haemonetics position as of Q4 2022 after selling out during the quarter.
  • Two Sigma Securities sold 2,996 Haemonetics shares in Q4 2022, an estimated $222K.
  • Two Sigma Securities first reported a position in Haemonetics in Q4 2019 and held it in 2 quarters.
  • Two Sigma Securities's Haemonetics position peaked at $255K in Q4 2019.
  • 294 funds tracked by Wall St. Rank held Haemonetics as of Q4 2022.

Based on Two Sigma Securities's 13F filing for Q4 2022, filed 14 Feb 2023.